REG - CVS Group plc - Total Voting Rights

CVSAnnouncement

29/05/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260529:nRSc1302Ga&default-theme=true

RNS Number : 1302G  CVS Group plc  29 May 2026

29 May 2026

 

CVS Group plc

("CVS" or the "Company")

Total Voting Rights

CVS, the UK listed veterinary group and a leading provider of veterinary
services, announces that, as of 29 May 2026, following cancellation of the
Ordinary Shares purchased pursuant to the Company's share buyback programme
(announced on 26 May 2026) prior to the date of this announcement, the
Company's total issued share capital consists of 70,022,712 ordinary shares of
0.2p each ("Ordinary Shares").

This figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest, or a change to their interest, in the Company under the FCA's
Disclosure Guidance and Transparency Rules.

Contacts:

 CVS Group plc                   via FGS Global
 Scott Morrison, Group General Counsel and Company Secretary

 FGS Global                      +44 (0)207 251 3801
 Faeth Birch                     cvsgroup@fgsglobal.com (mailto:cvsgroup@fgsglobal.com)
 Charlie Chichester

 

 

About CVS Group plc (www.cvsukltd.co.uk (http://www.cvsukltd.co.uk/) )

CVS Group is a leading provider of veterinary services, operating in the UK
and Australia, listed on the Main Market of the London Stock Exchange.  CVS
is focused on providing high-quality clinical services to its clients and
their animals, with outstanding and dedicated clinical teams and support
colleagues at the core of its strategy.

The Group operates over 475 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties) and an online retail
business ("Animed Direct").

The Group employs 9,000 personnel, including 2,500 veterinary surgeons and
3,300 nurses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TVRAKFBQABKDAPB



            Copyright 2019 Regulatory News Service, all rights reserved